- Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.
Rekstin Andrey et al. BioMed research international 2017 20179359276
- Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.
Alan Hampson et al. Vaccine 2017 Jan
- Influenza virus exploits tunneling nanotubes for cell-to-cell spread.
Kumar Amrita et al. Scientific reports 2017 Jan 740360
- Shifting clade distribution, reassortment, and emergence of new subtypes of highly pathogenic avian influenza A(H5) viruses collected in Vietnamese poultry from 2012 to 2015.
Nguyen Diep T et al. Journal of virology 2016 Dec
- Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
Isakova-Sivak Irina et al. Virology 2016 Nov 500209-217
domingo, 5 de marzo de 2017
INFLUENZA 3 || https://phgkb.cdc.gov/GAPPKB/phgHome.do
From CDC-Authored Genomics Publication Database
This database contains CDC-authored publications in public health genomics including infectious diseases, newborn screening, reproductive health, genetic testing, cancer, chronic diseases, birth defects and developmental disabilities, environmental and occupational health as well as laboratory, bioinformatics and statistical methods.